[Federal Register Volume 68, Number 138 (Friday, July 18, 2003)]
[Notices]
[Pages 42731-42732]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 03-18224]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[60Day-03-98]


Proposed Data Collections Submitted for Public Comment and 
Recommendations

    In compliance with the requirement of section 3506(c)(2)(A) of the 
Paperwork Reduction Act of 1995 for opportunity for public comment on 
proposed data collection projects, the Centers for Disease Control and 
Prevention (CDC) will publish periodic summaries of proposed projects. 
To request more information on the proposed projects or to obtain a 
copy of the data collection plans and instruments, call the CDC Reports 
Clearance Officer on (404) 498-1210.
    Comments are invited on: (a) Whether the proposed collection of 
information is necessary for the proper performance of the functions of 
the agency, including whether the information shall have practical 
utility; (b) the accuracy of the agency's estimate of the burden of the 
proposed collection of information; (c) ways to enhance the quality, 
utility, and clarity of the information to be collected; and (d) ways 
to minimize the burden of the collection of information on respondents, 
including through the use of automated collection techniques or other 
forms of information technology. Send comments to Anne O'Connor, CDC 
Assistant Reports Clearance Officer, 1600 Clifton Road, MS-D24, 
Atlanta, GA 30333. Written comments should be received within 60 days 
of this notice.

Proposed Project

    Evaluation of an intervention to increase colorectal cancer 
screening in primary care clinics--New--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC).
    Background and brief description of the proposed project: 
Colorectal cancer is the second leading cause of cancer-related deaths 
in the United States. Routine colorectal cancer screening is 
recommended for all men and women age 50 years and older. Many 
screening tests are widely available (e.g., fecal occult blood test, 
flexible sigmoidoscopy, colonoscopy), and all have been shown to be 
effective in reducing colorectal cancer mortality. Despite their 
effectiveness, colorectal cancer screening by any modality remains low. 
Some reasons attributed to the low screening rates include limited 
public awareness of colorectal cancer and the benefits of screening, 
failure of health care providers to recommend screening to patients, 
and inefficient surveillance and support systems in many health care 
settings. The purpose of this project is to evaluate a multi-component 
intervention to increase colorectal cancer screening among average-risk 
men and women in primary care clinics.
    The proposed study will consist of three tasks. In Task 1, 196 
primary care

[[Page 42732]]

clinicians will complete a survey assessing demographics; opinions 
about preventive services; colorectal cancer screening training and 
practices; colorectal cancer screening beliefs, facilitators, and 
barriers; and satisfaction with colorectal cancer screening. The survey 
will be administered to clinicians pre- and post-intervention. In Task 
2, 196 clinic support staff will complete a survey assessing 
demographics; work-related duties; opinions about preventive services; 
colorectal cancer screening training and practices; colorectal cancer 
screening beliefs, facilitators, and barriers; and satisfaction with 
colorectal cancer screening. The survey will be administered to clinic 
support staff pre- and post-intervention. In Task 3, clinic patients 
will complete a survey assessing demographics; health status; previous 
colorectal cancer screening and other preventive services received; 
colorectal cancer knowledge and opinions about colorectal cancer and 
colorectal cancer screening; and social support.
    The survey will be administered to 4,396 patients pre-intervention 
(consisting of 3,276 patients surveyed only at baseline and 1,120 
patients surveyed at baseline and follow-up) and 4,200 patients post-
intervention (consisting of 1,120 patients surveyed at baseline and 
follow-up and 3,080 patients surveyed only at follow-up). There are no 
costs to the respondents.

----------------------------------------------------------------------------------------------------------------
                                                                                      Average
                                                      No. of          No. of        burden per     Total burden
                   Respondents                      respondents    responses per   response  (in     (in hrs.)
                                                                    respondent         hrs.)
----------------------------------------------------------------------------------------------------------------
Clinicians......................................             196               2           30/60             196
Clinic support staff............................             196               2           25/60             163
Patients surveyed only at baseline..............            3276               1           20/60           1,092
Patients surveyed at baseline and follow-up.....            1120               2           20/60             747
Patients surveyed only at follow-up.............            3080               1           20/60           1,027
                                                 -----------------
    Total.......................................  ..............  ..............  ..............           3,225
----------------------------------------------------------------------------------------------------------------


    Dated: July 14, 2003.
Thomas A. Bartenfeld,
Acting Associate Director for Policy, Planning and Evaluation, Centers 
for Disease Control and Prevention.
[FR Doc. 03-18224 Filed 7-17-03; 8:45 am]
BILLING CODE 4163-18-P